Tuberculosis remains one of the most consequential infectious disease challenges of our era, and this landmark analysis arrives at a critical juncture: just as global health funding cuts threaten decades of hard-won gains, a comprehensive 33-year dataset now offers the clearest picture yet of where the world stands — and how far it must travel — before the WHO's 2035 elimination targets.
Drawing on the Global Burden of Disease Study 2023, this systematic analysis quantified TB mortality, morbidity, and disability-adjusted life-years (DALYs) across 204 countries and territories from 1990 through 2023. The investigators used the Cause of Death Ensemble model integrating vital registration, surveillance, verbal autopsy, and minimally invasive tissue sampling data — then layered in DisMod-MR 2.1 to simultaneously model incidence, prevalence, and mortality stratified by age, sex, HIV status, and drug-resistance profile. A population attributable fraction framework further disaggregated risk contributions from alcohol use, smoking, and elevated fasting plasma glucose, revealing modifiable upstream drivers that TB control programs rarely target directly. The dual burden of HIV-associated TB and multidrug-resistant TB (MDR-TB) received particular scrutiny, given their outsized contribution to DALYs and their resistance to standard treatment pathways.
This analysis is methodologically among the most rigorous TB burden assessments ever published, and its implications are sobering. The WHO End TB Strategy requires a 95% reduction in TB deaths and a 90% fall in incidence between 2015 and 2035 — trajectories that most regions were already failing to meet before recent funding contractions. The inclusion of MDR-TB stratification is especially valuable: drug-resistant strains now represent a disproportionate share of treatment costs and mortality, yet surveillance infrastructure in high-burden low-income countries remains patchy, introducing uncertainty in estimates. The identification of metabolic and behavioral risk factors — hyperglycemia, alcohol, smoking — as attributable TB drivers points toward an underexplored integration of chronic disease prevention with infectious disease control. For health-conscious adults globally, this study reinforces that TB is not merely a poverty-linked relic but a dynamic, evolving threat whose trajectory will depend heavily on sustained political and financial commitment over the next decade.